Viewing StudyNCT00501592



Ignite Creation Date: 2024-05-05 @ 6:33 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00501592
Status: COMPLETED
Last Update Posted: 2012-04-20
First Post: 2007-07-13

Brief Title: Study of INT-747 in Patients With Diabetes and Presumed NAFLD
Sponsor: Intercept Pharmaceuticals
Organization: Intercept Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Fatty Liver
Diabetes Mellitus Type II
Keywords:
Name View
Farnesoid X receptor agonist View
Metabolic Disorder View
Diabetes View
NAFLD View